News
Why Is Early-Onset CRC Rising? New Study Provides a Clue
- Author:
- M. Alexander Otto, PA, MMS
Publish date: May 21, 2025
News
FDA Approves Pfizer’s Hympavzi for Hemophilia A, B
- Author:
- M. Alexander Otto, PA, MMS
Publish date: October 15, 2024
News
FDA Panel Votes for Limits on Gastric, Esophageal Cancer Immunotherapy
- Author:
- M. Alexander Otto, PA, MMS
Publish date: September 30, 2024
News
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
- Author:
- M. Alexander Otto, PA, MMS
Publish date: September 23, 2024
News
Isatuximab Approved First-Line for Transplant-Ineligible MM
- Author:
- M. Alexander Otto, PA, MMS
Publish date: September 23, 2024
News
KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?
- Author:
- M. Alexander Otto, PA, MMS
Publish date: September 9, 2024
News
FDA Issues Complete Response Letter for Myeloma Drug
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 21, 2024
News
Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer Near Complete Responders?
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 20, 2024
News
FDA Approves Neoadjuvant/Adjuvant Durvalumab for NSCLC
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 16, 2024
News
Immunotherapy May Be Overused in Dying Patients With Cancer
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 8, 2024
News
FDA Approves First Engineered Cell Therapy for a Solid Tumor
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 2, 2024
News
FDA Calls AstraZeneca’s NSCLC Trial Design Into Question
- Author:
- M. Alexander Otto, PA, MMS
Publish date: July 30, 2024
News
Clinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?
- Author:
- M. Alexander Otto, PA, MMS
Publish date: July 5, 2024
News
FDA Approves Epcoritamab for R/R Follicular Lymphoma
- Author:
- M. Alexander Otto, PA, MMS
Publish date: June 27, 2024
News
Thermal Ablation Tops Surgery for Small CRC Liver Mets
- Author:
- M. Alexander Otto, PA, MMS
Publish date: June 26, 2024